TY - JOUR
T1 - Quantitative assessment of glucose metabolism in the vessel wall of abdominal aortic aneurysms
T2 - Correlation with histology and role of partial volume correction
AU - Reeps, Christian
AU - Bundschuh, Ralph A.
AU - Pellisek, Jaroslav
AU - Herz, Michael
AU - Van Marwick, Sandra
AU - Schwaiger, Markus
AU - Eckstein, Hans Henning
AU - Nekolla, Stephan G.
AU - Essler, Markus
PY - 2013/2
Y1 - 2013/2
N2 - Inflammatory-proteolytic processes in the vessel wall are essential in the pathophysiology of abdominal aortic aneurysm (AAA). It has been demonstrated that, 18F-FDG-PET/CT may be useful for detection of pathological wall metabolism and therefore risk stratification. Quantification of the FDG-uptake in AAA wall is hampered by partial-volume (PV)-effects. For correction and accurate quantitative 18F-FDG-uptake analysis we designed and validated a novel IDL-based software in correlation to phantom studies, histopathology and clinical presentation of AAA patients. For in vivo studies 23 patients with symptomatic and asymptomatic AAA underwent 18F-FDG- PET/CT before surgery. In areas with 18F-FDG-uptake the maximum and mean standardized uptake values in the vessel wall with (PVC-SUVmax, PVC-SUVmean) and without (SUVmax, SUVmean) PV-correction were determined. Results were correlated with clinical presentation, corresponding macrophage-infiltration and MMP-2- and -9-expression in surgical specimens. In patients, SUVmax, SUVmean as well as PVC-SUVmax or PVC-SUVmean enabled a highly significant (p < 0.005) discrimination of symptomatic and asymptomatic AAA. Uncorrected and corrected SUVs showed comparable correlations with macrophage-infiltration and MMP-9 expression. No correlation of 18F-FDG-uptake and MMP-2 was found. In vivo correlations of detected FDG-uptake with clinical and histological results showed comparable results for corrected and uncorrected SUVs. PV-correction is not mandatory for qualitative clinical assessment of glucose metabolism in the vessel wall of AAA-patients but may be necessary to establish quantitative cut off values to stratify patients for aneurysm repair.
AB - Inflammatory-proteolytic processes in the vessel wall are essential in the pathophysiology of abdominal aortic aneurysm (AAA). It has been demonstrated that, 18F-FDG-PET/CT may be useful for detection of pathological wall metabolism and therefore risk stratification. Quantification of the FDG-uptake in AAA wall is hampered by partial-volume (PV)-effects. For correction and accurate quantitative 18F-FDG-uptake analysis we designed and validated a novel IDL-based software in correlation to phantom studies, histopathology and clinical presentation of AAA patients. For in vivo studies 23 patients with symptomatic and asymptomatic AAA underwent 18F-FDG- PET/CT before surgery. In areas with 18F-FDG-uptake the maximum and mean standardized uptake values in the vessel wall with (PVC-SUVmax, PVC-SUVmean) and without (SUVmax, SUVmean) PV-correction were determined. Results were correlated with clinical presentation, corresponding macrophage-infiltration and MMP-2- and -9-expression in surgical specimens. In patients, SUVmax, SUVmean as well as PVC-SUVmax or PVC-SUVmean enabled a highly significant (p < 0.005) discrimination of symptomatic and asymptomatic AAA. Uncorrected and corrected SUVs showed comparable correlations with macrophage-infiltration and MMP-9 expression. No correlation of 18F-FDG-uptake and MMP-2 was found. In vivo correlations of detected FDG-uptake with clinical and histological results showed comparable results for corrected and uncorrected SUVs. PV-correction is not mandatory for qualitative clinical assessment of glucose metabolism in the vessel wall of AAA-patients but may be necessary to establish quantitative cut off values to stratify patients for aneurysm repair.
KW - Abdominal aortic aneurysm
KW - Nuclear imaging
KW - PET/CT
KW - Partial volume correction
UR - http://www.scopus.com/inward/record.url?scp=84879685814&partnerID=8YFLogxK
U2 - 10.1007/s10554-012-0090-9
DO - 10.1007/s10554-012-0090-9
M3 - Article
C2 - 22772434
AN - SCOPUS:84879685814
SN - 1569-5794
VL - 29
SP - 505
EP - 512
JO - International Journal of Cardiovascular Imaging
JF - International Journal of Cardiovascular Imaging
IS - 2
ER -